YEATS2 Inhibitors

Chemical inhibitors of YEATS2 can target the protein's interaction with chromatin, a crucial aspect of its function within the cell. Trichostatin A, Vorinostat, Panobinostat, Romidepsin, Entinostat, Belinostat, SAHA, Mocetinostat, Givinostat, Quisinostat, and CUDC-101 are all inhibitors of histone deacetylases (HDACs). The inhibition of HDACs by these chemicals results in hyperacetylation of histone proteins. This hyperacetylation affects the interaction between histones and DNA, leading to a more relaxed chromatin structure. Because YEATS2 is known to bind acetylated lysine residues on histones, the hyperacetylation of histones can disrupt the normal function of YEATS2 by altering its chromatin-binding dynamics. As such, the presence of these HDAC inhibitors can prevent YEATS2 from engaging with chromatin in its regular manner, thereby inhibiting its function.

Another approach to inhibiting YEATS2 involves the use of MG-132, a proteasome inhibitor. By blocking the proteasome's function, MG-132 causes an accumulation of ubiquitinated proteins, which may include YEATS2 itself. This accumulation can lead to an increased degradation of proteins, including potentially YEATS2, through the ubiquitin-proteasome system. As the degradation process of YEATS2 is enhanced, the overall levels and activity of the protein within the cell are reduced. Consequently, this results in the functional inhibition of YEATS2 as its availability to participate in its normal biological processes is diminished.